Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 26:2024:4835223.
doi: 10.1155/crcc/4835223. eCollection 2024.

A Singular Case Analysis: Lamotrigine-Associated Stevens-Johnson Syndrome

Affiliations
Case Reports

A Singular Case Analysis: Lamotrigine-Associated Stevens-Johnson Syndrome

Albin Joshi et al. Case Rep Crit Care. .

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is an immune complex-mediated hypersensitivity reaction linked as an adverse side effect to many drugs. There have been case reports of similar incidences in Nepal related to various medications. Here, we present a case of a 29-year-old lady who developed a generalized erythematous rash over her body and erosion of the oral mucous membrane. Two weeks back she gave a history of initiation of lamotrigine, olanzapine, and sertraline. Given the strong association between SJS and lamotrigine, and the usual presentation being within the first 8 weeks of exposure to susceptible medications; she was diagnosed as SJS/TEN induced by lamotrigine. On April 1, 2024, she was admitted to the ICU at KIST MCTH. All the medicines were withheld, and she was managed with corticosteroids and antihistamines. She improved significantly within 7 days. Early identification of SJS, discontinuation of triggering medicines, and prompt initiation of supportive therapy improved the prognosis.

Keywords: Stevens–Johnson syndrome (SJS); adverse drug reaction (ADR); antiepileptic drugs; case report; lamotrigine; toxic epidermal necrolysis (TEN).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Initial presentation of oral mucosa erosion and maculopapular rashes.
Figure 2
Figure 2
Flowchart of a sequence of events of the patient leading to SJS/TEN diagnosis.
Figure 3
Figure 3
Oral mucosa erosion and rashes present during ICU stay.
Figure 4
Figure 4
Resolving oral mucosa erosion and rashes during ward stay.
Figure 5
Figure 5
Adverse drug reaction alert sticker implementation in the patient document.

References

    1. WHO_EDM_QSM_2002.2.pdf. [cited 2024 May 11]. https://iris.who.int/bitstream/handle/10665/67378/WHO_EDM_QSM_2002.2.pdf....
    1. Jha N., Bajracharya O., Namgyal T. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. Kathmandu University Medical Journal (KUMJ) . 2007;5(4):504–510. - PubMed
    1. Patel P. P., Gandhi A. M., Desai C. K., Desai M. K., Dikshit R. K. An analysis of drug induced Stevens-Johnson syndrome. The Indian Journal of Medical Research . 2012;136(6):1051–1053. - PMC - PubMed
    1. Chan H. L., Stern R. S., Arndt K. A., et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Archives of Dermatology . 1990;126(1):43–47. doi: 10.1001/archderm.1990.01670250049006. - DOI - PubMed
    1. Acharya A., Acharya S. P., Bhattarai T. Cotrimoxazole induced Steven Johnson syndrome: a case report. JNMA: Journal of the Nepal Medical Association . 2020;58(229):702–704. doi: 10.31729/jnma.4999. - DOI - PMC - PubMed

Publication types

LinkOut - more resources